SynPlexity
Printing DNA sequences that are longer and at a cheaper price point.
SynPlexity is active in the industrial research tools space based in United States, founded in 2024.
Profile
SynPlexity prints massively parallel amounts of DNA sequences – longer and cheaper than anything else. SynPlexity’s tech will unlock new levels of experimentation and training data for synthetic biology and generative protein AI.
The company sits in the industrial research tools segment, where it competes on its core product or service.
The company is recorded as being based in United States.
It is recorded at the SOSV portfolio company stage.
The company reports a headcount in the 2-10 range.
It has disclosed roughly $58K in funding.
| Sector | Industrial Research Tools |
|---|---|
| Country | United States |
| Founded | 2024 |
| Employees | 2-10 |
| Stage | SOSV portfolio company |
| Total funding | $580,000 |
Website: synplexity.com
Browse related
Sign in to view the contact information we hold for SynPlexity.
Create a free account
Create a free account